rf-fullcolor.png

 

February 14, 2023
by Joanne S. Eglovitch

Recon: FDA declines to review Soligenix’s lymphoma drug; GSK pulls out of COVID deal with Vir

Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.
 
In Focus: US
  • FDA Rejects Soligenix’s Lymphoma Candidate (BioSpace) (Reuters) (Endpoints) (Fierce)
  • OTC Naloxone In US Could Limit Access Due To Costs, Comments On Emergent Switch NDA Argue (Pink Sheet)
  • FDA rejects Biocon and Viatris' Avastin biosimilar after inspection question marks (Endpoints)
  • Scientific institutions must embrace antiracist policies, National Academies report urges (STAT)
  • House GOP Seeks Fauci Testimony in Probe of Covid-19 Origins (Bloomberg)
  • House readies first GOP-led COVID vaccine probe (Axios)
  • Drug Price Negotiations Need ‘Nimble’ Approach, Official Says (Bloomberg) (Pink Sheet)
  • Johnson & Johnson names ex-Sanofi executive as pharma, R&D vice president (Reuters)
In Focus: International
  • NYT sues European Commission over failure to reveal text messages with Pfizer CEO Albert Bourla (Fierce)
  • Germany proposes to fix shortages in certain medicines (Reuters)
  • Freezing UK Statutory Scheme Rebate Could Cost UK Government Over £15m (Pink Sheet)
  • WHO increasing health surveillance after Equatorial Guinea finds Marburg virus (Reuters) (Washington Post)
  • Eli Lilly strikes 2nd deal to boost affordable insulin access, this time in Bangladesh (Fierce)
Pharma & Biotech
  • GSK nixes next-gen COVID-19 antibody collaboration, leaving Vir to fly solo, seek new partners (Fierce) (Biospace) (Endpoints)
  • With $520 million in hand, two entrepreneurs try to upend the biotech funding model (STAT)
  • Korea Q4 Roundup: International Growth A Key Factor For Major Firms (Scrip)
  • Viz.ai Collaborates with Johns Hopkins to Expedite Enrollment in Brain Injury Trial (BioSpace)
Medtech
  • When Is An IVD A CDx? EU IVDR Guidance Updated To Include Flowchart (MedTech Insight)
  • Diagnostics Industry Helps MHRA Shape IVDs Roadmap As Part Of Future UK Regulation (MedTech Insight)
  • Alcon to pay J&J $199M to settle dispute over patents for laser eye surgery device (MedTech Dive) (Fierce)
  • Vicarious Surgical lays off 14% of workers to get its VR-powered robotics ‘out the door fast’ (Fierce)
Government, Regulatory and Legal
  • Judge indicates intention to dismiss J&J talc unit faces bankruptcy bid (Reuters)
  • US government, Pfizer and others side with Sanofi and Regeneron in Supreme Court patent case (Endpoints)
  • Merck, Glenmark headed to trial after judge scraps early dismissal bid in Zetia antitrust case (Fierce) (Bloomberg)
  • Spacelabs Reaches Settlement Over Allegedly Overcharging VA, DOD (Bloomberg)
 
Regulatory Recon is our daily intelligence briefing for the regulatory affairs space, bringing you the top regulatory, biopharma and medtech news stories from around the globe.
 
A story’s inclusion in Regulatory Recon does not imply endorsement by Regulatory Focus or RAPS.
×

Welcome to the new RAPS Digital Experience

We have completed our migration to a new platform and are pleased to introduce the updated site.

What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.

We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.

We welcome your feedback. Please let us know how we can continue to improve your experience.